• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液生物标志物在轻度认知障碍和阿尔茨海默病的早期诊断中的应用。

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease.

机构信息

Department of Biomedical Sciences, School of Health Sciences, International Hellenic University, Alexandrion University Campus, 57400 Sindos, Greece.

Laboratory of Medical Biology-Genetics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

出版信息

Int J Mol Sci. 2023 May 19;24(10):8976. doi: 10.3390/ijms24108976.

DOI:10.3390/ijms24108976
PMID:37240322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10218948/
Abstract

Alzheimer's disease (AD) is a rapidly growing disease that affects millions of people worldwide, therefore there is an urgent need for its early diagnosis and treatment. A huge amount of research studies are performed on possible accurate and reliable diagnostic biomarkers of AD. Due to its direct contact with extracellular space of the brain, cerebrospinal fluid (CSF) is the most useful biological fluid reflecting molecular events in the brain. Proteins and molecules that reflect the pathogenesis of the disease, e.g., neurodegeneration, accumulation of Abeta, hyperphosphorylation of tau protein and apoptosis may be used as biomarkers. The aim of the current manuscript is to present the most commonly used CSF biomarkers for AD as well as novel biomarkers. Three CSF biomarkers, namely total tau, phospho-tau and Abeta42, are believed to have the highest diagnostic accuracy for early AD diagnosis and the ability to predict AD development in mild cognitive impairment (MCI) patients. Moreover, other biomarkers such as soluble amyloid precursor protein (APP), apoptotic proteins, secretases and inflammatory and oxidation markers are believed to have increased future prospects.

摘要

阿尔茨海默病(AD)是一种快速增长的疾病,影响着全球数以百万计的人,因此迫切需要对其进行早期诊断和治疗。大量的研究致力于寻找 AD 的准确、可靠的诊断生物标志物。由于其直接接触大脑的细胞外间隙,脑脊液(CSF)是反映大脑内分子事件的最有用的生物液体。可以将反映疾病发病机制的蛋白质和分子(如神经退行性变、Abeta 积累、tau 蛋白过度磷酸化和细胞凋亡)用作生物标志物。本文的目的是介绍 AD 最常用的 CSF 生物标志物以及新的生物标志物。有三种 CSF 生物标志物,即总 tau、磷酸化 tau 和 Abeta42,被认为对早期 AD 诊断具有最高的诊断准确性,并且能够预测轻度认知障碍(MCI)患者的 AD 发展。此外,其他生物标志物,如可溶性淀粉样前体蛋白(APP)、凋亡蛋白、分泌酶和炎症及氧化标志物,被认为具有更大的应用前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea40/10218948/51dfcc34eead/ijms-24-08976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea40/10218948/40a9d5c64ece/ijms-24-08976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea40/10218948/51dfcc34eead/ijms-24-08976-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea40/10218948/40a9d5c64ece/ijms-24-08976-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea40/10218948/51dfcc34eead/ijms-24-08976-g002.jpg

相似文献

1
CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease.脑脊液生物标志物在轻度认知障碍和阿尔茨海默病的早期诊断中的应用。
Int J Mol Sci. 2023 May 19;24(10):8976. doi: 10.3390/ijms24108976.
2
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
3
Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.在OPTIMA队列中,脑脊液生物标志物可将经尸检确诊的阿尔茨海默病与其他痴呆症及健康对照区分开来。
J Alzheimers Dis. 2015;44(2):525-39. doi: 10.3233/JAD-141725.
4
Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.脑脊液S100B蛋白与前驱期和轻度阿尔茨海默病核心生物标志物及认知缺陷的关联
J Alzheimers Dis. 2019;72(4):1119-1127. doi: 10.3233/JAD-190550.
5
Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.载脂蛋白 E 基因型与阿尔茨海默病脑脊液生物标志物的诊断准确性。
JAMA Psychiatry. 2014 Oct;71(10):1183-91. doi: 10.1001/jamapsychiatry.2014.1060.
6
Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.外周血管内皮功能障碍标志物与阿尔茨海默病相关的脑内生物标志物具有独立但累加的关系,并与功能障碍相关。
J Alzheimers Dis. 2021;80(4):1553-1565. doi: 10.3233/JAD-200759.
7
The role of cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis. where are we now?脑脊液生物标志物在阿尔茨海默病诊断中的作用。我们目前处于什么阶段?
Recent Pat CNS Drug Discov. 2013 Apr;8(1):70-8. doi: 10.2174/1574889811308010006.
8
Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network.不要忽视 tau:载脂蛋白 E4 基因型对轻度认知障碍患者阿尔茨海默病脑脊液生物标志物的影响——来自痴呆能力网络的数据。
J Neural Transm (Vienna). 2022 Jun;129(5-6):477-486. doi: 10.1007/s00702-022-02461-0. Epub 2022 Jan 21.
9
Soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for differential diagnosis of mild cognitive impairment.脑脊液中可溶性 APP-α 和 APP-β 作为轻度认知障碍鉴别诊断的潜在生物标志物。
Aging Clin Exp Res. 2022 Feb;34(2):341-347. doi: 10.1007/s40520-021-01935-7. Epub 2021 Jul 20.
10
Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.老年双相情感障碍中的认知障碍与脑脊液中的阿尔茨海默病病理特征无关。
Bipolar Disord. 2016 Feb;18(1):63-70. doi: 10.1111/bdi.12360. Epub 2016 Feb 15.

引用本文的文献

1
P-tau217 as a Biomarker in Alzheimer's Disease: Applications in Latin American Populations.P-tau217作为阿尔茨海默病的生物标志物:在拉丁裔人群中的应用。
Int J Mol Sci. 2025 Jul 10;26(14):6633. doi: 10.3390/ijms26146633.
2
The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?自身抗体在阿尔茨海默病中的作用:致病关联还是附带现象?
Alzheimers Dement. 2025 Jul;21(7):e70484. doi: 10.1002/alz.70484.
3
Integrative single-cell and cell-free plasma RNA transcriptomics identifies biomarkers for early non-invasive AD screening.

本文引用的文献

1
Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample.基于人群样本的轴突和突触退化的脑脊液生物标志物。
Alzheimers Res Ther. 2023 Mar 3;15(1):44. doi: 10.1186/s13195-023-01193-x.
2
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.神经退行性疾病中的神经丝轻链寡聚体:通过脑脊液中的均相免疫测定进行定量分析
BMJ Neurol Open. 2023 Feb 27;5(1):e000395. doi: 10.1136/bmjno-2022-000395. eCollection 2023.
3
Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
整合单细胞和无细胞血浆RNA转录组学可识别早期非侵入性阿尔茨海默病筛查的生物标志物。
Front Aging Neurosci. 2025 May 30;17:1571783. doi: 10.3389/fnagi.2025.1571783. eCollection 2025.
4
Tablet-Based Assessment of Picture Naming in Prodromal Alzheimer's Disease: An Accessible and Effective Tool for Distinguishing Mild Cognitive Impairment from Normal Aging.基于平板电脑的前驱期阿尔茨海默病图片命名评估:一种区分轻度认知障碍与正常衰老的便捷有效工具。
Dement Geriatr Cogn Disord. 2025 Jun 11:1-12. doi: 10.1159/000546451.
5
Heat shock protein 90α may serve as a biomarker for mild cognitive impairment in type 2 diabetes mellitus patients without diabetic nephropathy.热休克蛋白90α可能作为无糖尿病肾病的2型糖尿病患者轻度认知障碍的生物标志物。
Front Immunol. 2025 May 12;16:1516975. doi: 10.3389/fimmu.2025.1516975. eCollection 2025.
6
Peripheral blood heat shock protein 27 correlates with information processing speed and executive function, potentially serving as a marker for mild cognitive impairment in patients with type 2 diabetes mellitus.外周血热休克蛋白27与信息处理速度和执行功能相关,可能作为2型糖尿病患者轻度认知障碍的一个标志物。
Diabetol Metab Syndr. 2025 May 24;17(1):167. doi: 10.1186/s13098-025-01747-z.
7
Prospecting salivary tau as a diagnostic for Alzheimer's type dementia.探索唾液tau蛋白作为阿尔茨海默病型痴呆的诊断标志物。
Dement Neuropsychol. 2025 Apr 28;19:e20240253. doi: 10.1590/1980-5764-DN-2024-0253. eCollection 2025.
8
Associations of moderate alcohol intake with cerebrospinal fluid biomarkers of Alzheimer's disease: data from the ALBION study.适度饮酒与阿尔茨海默病脑脊液生物标志物的关联:来自ALBION研究的数据。
Eur J Nutr. 2025 Apr 1;64(3):142. doi: 10.1007/s00394-025-03651-8.
9
Dual orexin receptor antagonists as promising therapeutics for Alzheimer's disease.双重食欲素受体拮抗剂有望成为治疗阿尔茨海默病的药物。
NPJ Biol Timing Sleep. 2025;2(1):11. doi: 10.1038/s44323-025-00025-5. Epub 2025 Mar 8.
10
Clinical practice guidelines for assessment and management of mild neurocognitive disorder.轻度神经认知障碍评估与管理的临床实践指南
Indian J Psychiatry. 2025 Jan;67(1):21-40. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_693_24. Epub 2025 Jan 13.
脑脊液神经退行性变生物标志物与阿尔茨海默病和血管病理学标志物的相关性。
J Alzheimers Dis. 2023;92(3):887-898. doi: 10.3233/JAD-221015.
4
Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis.神经丝分析对肌萎缩侧索硬化症诊断延迟的影响。
CNS Neurosci Ther. 2023 Jan;29(1):70-77. doi: 10.1111/cns.13960. Epub 2022 Sep 1.
5
Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.脑脊液总 tau 和磷酸化 tau 在散发性克雅氏病和快速进展性阿尔茨海默病鉴别诊断中的应用。
Viruses. 2022 Jan 28;14(2):276. doi: 10.3390/v14020276.
6
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.基于生物流体的阿尔茨海默病相关病理生物标志物:文献综述与更新。
Alzheimers Dement. 2022 Sep;18(9):1687-1693. doi: 10.1002/alz.12618. Epub 2022 Feb 25.
7
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease.脑脊液 p-tau231 作为阿尔茨海默病早期发病机制的生物标志物。
EBioMedicine. 2022 Feb;76:103836. doi: 10.1016/j.ebiom.2022.103836. Epub 2022 Feb 12.
8
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.从脑脊液检测向血液检测转变,以促进阿尔茨海默病的诊断和疾病监测。
J Intern Med. 2021 Sep;290(3):583-601. doi: 10.1111/joim.13332. Epub 2021 Jun 26.
9
Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis.神经颗粒蛋白和 VILIP-1 作为阿尔茨海默病神经退行性变的分子标志物:系统评价和荟萃分析。
Int J Mol Sci. 2020 Nov 6;21(21):8335. doi: 10.3390/ijms21218335.
10
BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients.脑啡肽酶 1 和其他与阿尔茨海默病相关的生物标志物在脑脊液和血浆中的差异可区分阿尔茨海默病患者和认知障碍神经梅毒患者。
J Alzheimers Dis. 2020;77(1):313-322. doi: 10.3233/JAD-200362.